Kaplan-Meier graphs for breast cancer incidence in the tamoxifen

IJMS, Free Full-Text

Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters

Ivana SESTAK, Associate Professor in Medical Statistics

Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study

The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies

Tamoxifen related side effects and their impact on breast cancer

Frontiers Risk of Endometrial Cancer and Frequencies of Invasive Endometrial Procedures in Young Breast Cancer Survivors Treated With Tamoxifen: A Nationwide Study

Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research

Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy - ScienceDirect

Kaplan-Meier graphs for breast cancer incidence in the tamoxifen

Progress in preventive therapy for cancer: a reminiscence and personal viewpoint

CCNA2 Is a Prognostic Biomarker for ER+ Breast Cancer and Tamoxifen Resistance